• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) JUVEDERM VOLUMA WITH LIDOCAINE 1ML SKU1; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) JUVEDERM VOLUMA WITH LIDOCAINE 1ML SKU1; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 94506JR
Device Problem Material Too Rigid or Stiff (1544)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 09/04/2017
Event Type  malfunction  
Manufacturer Narrative
A review of the device history record has been completed.No deviations or non-conformances noted.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Device labeling for material rigid or stiff: device description: juvéderm voluma® xc is a sterile, biodegradable, non-pyrogenic, viscoelastic, clear, colorless, homogeneous gel implant.It consists of crosslinked hyaluronic acid (ha) produced by streptococcus species of bacteria, formulated to a concentration of 20 mg/ml and 0.3% w/w lidocaine in a physiologic buffer.Precautions: ¿ juvéderm voluma® xc is to be used as supplied.Modification or use of the product outside the directions for use may adversely impact the sterility, homogeneity, and performance of the product.How supplied: juvéderm voluma® xc injectable gel is supplied in individual treatment syringes with needles as indicated on the carton.Juvéderm voluma® xc can be injected with either a 27g ½" or a 25g 1" needle.The volume in each syringe is as stated on the syringe label and on the carton.The contents of the syringe are sterile and non-pyrogenic.Do not resterilize.Do not use if package is open or damaged.Shelf life and storage: juvéderm voluma® xc injectable gel has a clear appearance.In the event that a syringe contains material that is not clear, do not use the syringe.
 
Event Description
Healthcare professional reported injecting a patient with juvéderm® voluma¿ with lidocaine in the right temple using the packaged needle.Initial use of the syringe.During the injection, the healthcare professional saw "a crystallized from of hyaluronic acid inside the syringe." the healthcare professional then stopped the injection and removed the device from the patient.Injection was completed with another syringe.Patient is fine with no adverse event.
 
Manufacturer Narrative
Lab analysis of the device found no defect.
 
Event Description
Healthcare professional reported injecting a patient with juvéderm® voluma¿ with lidocaine in the right temple using the packaged needle.Initial use of the syringe.During the injection, the healthcare professional saw "a crystallized from of hyaluronic acid inside the syringe." the healthcare professional then stopped the injection and removed the device from the patient.Injection was completed with another syringe.Patient is fine with no adverse event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JUVEDERM VOLUMA WITH LIDOCAINE 1ML SKU1
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR  74370
Manufacturer (Section G)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR   74370
Manufacturer Contact
suzanne wojcik
301 w howard lane
suite 100
austin, TX 78753
7372473605
MDR Report Key6930928
MDR Text Key89955387
Report Number3005113652-2017-01132
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
Reporter Country CodeSN
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/23/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2018
Device Catalogue Number94506JR
Device Lot NumberVB20A60272
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/09/2017
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/12/2017
Initial Date FDA Received10/09/2017
Supplement Dates Manufacturer Received10/09/2017
Supplement Dates FDA Received10/23/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/21/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-